Daniel G. Bichet
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 108 publications
GLUT9b- and ABCG2-mediated collecting duct urate transport uncover a vasopressin-independent mechanism of renal water reabsorption.
Journal: The Journal of clinical investigation
Published: June 16, 2026
Response to "Beyond Pain: Sarcopenia, Malnutrition, and Sex-Specific Body Image Distortion as Potential Additional Mediators of HRQOL Impairment in ADPKD".
Journal: Kidney international reports
Published: May 20, 2026
Canadian Society of Nephrology Commentary on the 2025 Kidney Disease Improving Global Outcomes Clinical Practice Guidelines for Autosomal Dominant Polycystic Kidney Disease.
Journal: Canadian journal of kidney health and disease
Published: January 21, 2026
Association of Kidney Volume With Patient-Reported Outcomes in ADPKD.
Journal: Kidney international reports
Published: September 28, 2025
GLUT9b- and ABCG2-mediated collecting duct urate transport uncovers a vasopressin-independent mechanism of renal water reabsorption.
Journal: The Journal of clinical investigation
Published: June 20, 2025
Eight Years of Canadian Real-World Assessment of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease: The C-MAJOR Registry.
Journal: Canadian journal of kidney health and disease
Published: June 11, 2025
Author Correction: Diabetes insipidus.
Journal: Nature reviews. Disease primers
Published: June 04, 2025
International expert consensus statement on the diagnosis and management of congenital nephrogenic diabetes insipidus (arginine vasopressin resistance).
Journal: Nature reviews. Nephrology
Published: September 13, 2024
Thirst, Hunger, and Nephrogenic Diabetes Insipidus.
Journal: The New England journal of medicine
Published: May 29, 2024
G protein-coupled receptor (GPCR) gene variants and human genetic disease.
Journal: Critical reviews in clinical laboratory sciences
Published: March 18, 2024
Renal and multisystem effectiveness of 3.9 years of migalastat in a global real-world cohort: Results from the followME Fabry Pathfinders registry.
Journal: Journal of inherited metabolic disease
Published: March 12, 2024
Last Updated: 09/26/2026